BioDiem Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioDiem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12401
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company’s product portfolio includes Live Attenuated Influenza Virus (LAIV) vaccine technology, used for production of seasonal and pandemic influenza vaccines and antimicrobial BDM-I for the treatment of serious human infections. BioDiem partners with other vaccine and infectious disease treatment companies through licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organisation as part of the Global Pandemic Influenza Action Plan. BioDiem is headquartered in South Melbourne, Victoria, Australia.

BioDiem Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioDiem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioDiem Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
BioDiem Enters Into Research Agreement With RMIT University For Non-Influenza Vaccines 10
BioDiem Enters into Partnership with National Neurovision Research Institute and University of Miami 11
Licensing Agreements 12
BioDiem Enters Into Licensing Agreement With University of Canberra For Hepatitis Vaccine Technology 12
BioDiem Enters Into Licensing Agreement With Australian National University For Infectious Vaccine Technology 13
BioDiem Enters Into Licensing Agreement With Changchun BCHT Biotech For LAIV Vaccine Technology 14
Equity Offering 15
BioDiem Completes Rights Issue Of Shares For US$2 Million 15
BioDiem Ltd – Key Competitors 16
BioDiem Ltd – Key Employees 17
BioDiem Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Mar 17, 2017: BioDiem Announces its Half Year Results 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
BioDiem Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioDiem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioDiem Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioDiem Enters Into Research Agreement With RMIT University For Non-Influenza Vaccines 10
BioDiem Enters into Partnership with National Neurovision Research Institute and University of Miami 11
BioDiem Enters Into Licensing Agreement With University of Canberra For Hepatitis Vaccine Technology 12
BioDiem Enters Into Licensing Agreement With Australian National University For Infectious Vaccine Technology 13
BioDiem Enters Into Licensing Agreement With Changchun BCHT Biotech For LAIV Vaccine Technology 14
BioDiem Completes Rights Issue Of Shares For US$2 Million 15
BioDiem Ltd, Key Competitors 16
BioDiem Ltd, Key Employees 17
BioDiem Ltd, Subsidiaries 18

List of Figures
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BioDiem Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HanAll Biopharma Co Ltd (009420):製薬・医療:M&Aディール及び事業提携情報
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a pharmaceutical company that offers drug delivery, biotherapeutics, and small molecule discovery programs. The company develops drugs in therapeutic areas of ophthalmology, immunology, cardiovascular disease, dermat …
  • Jamnica dd:企業の戦略・SWOT・財務分析
    Jamnica dd - Strategy, SWOT and Corporate Finance Report Summary Jamnica dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • TOA Corporation:企業の戦略・SWOT・財務分析
    TOA Corporation - Strategy, SWOT and Corporate Finance Report Summary TOA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Population Genetics Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Population Genetics Technologies Ltd (Population Genetics) is a biotechnology company that offers diagnostic test solutions. The company provides products such as diagnostic test kits, HIV diagnostic test systems, and HCV diagnostic test systems. Its diagnostic test kits provide reagent assa …
  • Pulmagen Therapeutics LLP:製薬・医療:M&Aディール及び事業提携情報
    Summary Pulmagen Therapeutics LLP (Pulmagen) formerly Argenta Discovery Ltd, is a development stage pharmaceutical company, which develops oral and inhaled medicines for chronic respiratory diseases. The company’s product pipeline includes oral CRTh2 antagonists, inhaled bronchodilators, inhaled per …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose) is an investment company that improve and sell industrial and manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipment. Its business portfolio comprises of Norte …
  • International CSRC Investment Holdings Co Ltd (2104):企業の財務・戦略的SWOT分析
    International CSRC Investment Holdings Co Ltd (2104) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Croatia Airlines dd:戦略・SWOT・企業財務分析
    Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Old Mutual Plc:戦略・SWOT・企業財務分析
    Old Mutual Plc - Strategy, SWOT and Corporate Finance Report Summary Old Mutual Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ardian Holding SAS:企業の戦略的SWOT分析
    Ardian Holding SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Kumho Petrochemical Co Ltd (011780):企業の財務・戦略的SWOT分析
    Kumho Petrochemical Co Ltd (011780) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Hackett Group, Inc.:企業の戦略・SWOT・財務分析
    The Hackett Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hackett Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Makita Corporation (6586):企業の財務・戦略的SWOT分析
    Makita Corporation (6586) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bend Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocess …
  • Sumitomo Corp (8053):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Reliance General Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance General Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • BP Plc (BP.):企業の財務・戦略的SWOT分析
    BP Plc (BP.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Capital Senior Living Corp (CSU):製薬・医療:M&Aディール及び事業提携情報
    Summary Capital Senior Living Corp (Capital Senior Living) is engaged in providing residential communities for elderly population. The company offers various living accommodations and supportive services including senior living services, independent living services, assisted living services includin …
  • Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega- …
  • Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Icon Genetics GmbH (Icon Genetics), a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆